Detalhe da pesquisa
1.
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.
Ophthalmology
; 130(7): 735-747, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870451
2.
Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR.
Graefes Arch Clin Exp Ophthalmol
; 260(8): 2437-2447, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239009
3.
Relationship between retinal fluid characteristics and vision in neovascular age-related macular degeneration: HARBOR post hoc analysis.
Graefes Arch Clin Exp Ophthalmol
; 260(12): 3781-3789, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687173
4.
Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 127(10): 1360-1370, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402555
5.
Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 127(4): 523-532, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718842
6.
MACULAR ATROPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Pilot Post Hoc Analysis of Patients With Pigment Epithelial Detachments.
Retina
; 40(2): 266-272, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31972796
7.
Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
Ophthalmology
; 125(10): 1568-1574, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752001
8.
Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE.
Ophthalmology
; 123(6): 1345-50, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26992841
9.
Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study.
Ophthalmology
; 123(10): 2213-24, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27566855
10.
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly Injections.
Am J Ophthalmol
; 258: 158-172, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453472
11.
Characteristics that Correlate with Macular Atrophy in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration.
Ophthalmol Retina
; 7(4): 300-306, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372347
12.
Prevalence of Macular Atrophy in the MARINA Study of Ranibizumab versus Sham for Neovascular Age-Related Macular Degeneration.
Ophthalmol Retina
; 7(8): 661-671, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086257
13.
Fluctuations in central foveal thickness and association with vision outcomes with anti-VEGF therapy for nAMD: HARBOR post hoc analysis.
BMJ Open Ophthalmol
; 7(1): e000957, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35342822
14.
Prevalence and Progression of Macular Atrophy in Eyes with Neovascular Age-Related Macular Degeneration in the Phase 2 Ladder Trial of the Port Delivery System with Ranibizumab.
Ophthalmol Retina
; 6(9): 786-795, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35427803
15.
Implantation Site of a Port Delivery System With Ranibizumab: Anterior Segment Optical Coherence Tomography Evaluation.
J Vitreoretin Dis
; 6(5): 347-350, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-37006905
16.
Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration.
Am J Ophthalmol
; 233: 8-17, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289338
17.
Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
JAMA Ophthalmol
; 140(8): 771-778, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708706
18.
Implant Insertion Procedure of the Port Delivery System With Ranibizumab: Overview and Clinical Pearls.
Ophthalmic Surg Lasers Imaging Retina
; 53(5): 249-256, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575736
19.
Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration.
Ophthalmol Ther
; 11(5): 1705-1717, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759124
20.
Management of Key Ocular Adverse Events in Patients Implanted with the Port Delivery System with Ranibizumab.
Ophthalmol Retina
; 6(11): 1028-1043, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589078